Dilated cardiomyopathy (DCM) is a heterogeneous disorder that is familial in approximately 30% of cases. Although several genes have been identified that can cause familial DCM, molecular analyses ...
It is divided into four chambers: the upper two atria are the receiving chambers and the lower two ventricles are the pumping chambers. Dilated cardiomyopathy (DCM) causes the heart to become enlarged ...
Cellipont Bioservices and Secretome Therapeutics are set to enter a collaboration in the manufacture of the latter’s cellular therapy, STM-01. The collaboration will see Cellipont offering technology ...
Affinia Therapeutics Inc. has nominated AFTX-201 as a development candidate for the treatment of BAG3 dilated cardiomyopathy. The gene therapy, using Affinia’s cardiotropic capsid, is given as a ...
Penelope Greathead, from Ravenscar, suffers from a condition known as dilated cardiomyopathy and has been on life support at Leeds Children's Hospital since suffering heart failure two weeks ago.